CSTL - Balance Sheet - Castle Biosciences, Inc.

Current Liabilities	49.4 M
Accounts Payable	6.9 M
Short-Term Debt	278 K
Other Current Liabilities	42.2 M
Non-Current Liabilities	26 M
Long-Term Debt	9.74 M
Other Non-Current Liabilities	16.3 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017
ASSETS
Cash & Cash Equivalents	119.7	98.8	122.9	329.6	409.9	98.8	4.5	1.2
Short Term Investments	173.4	144.3	135.7	0	0	0	0	0
Receivables	51.2	38.3	23.5	17.3	12.8	14.6	12.1	4.7
Inventory	8.1	7.9	4.0	2.0	2.2	1.2	0.9	0.3
Other Current Assets	7.7	6.3	6.2	9.6	9.5	3.9	0.7	0.5
Total Current Assets	360.2	295.6	292.3	353.7	429.6	116.7	18.1	6.7
PP&E	62.7	37.7	26.5	16.9	7.1	2.1	1.5	1.5
Intangible Assets	95.5	106.6	115.7	88.9	0	0	4.17 K	40.1 K
Goodwill	10.7	10.7	10.7	0	0	0	0	0
Long Term Investments	0	0	1.1	1.3	1.1	0.9	2.5	1.6
Other Long Term Assets	2.1	2.6	(25.6)	3.0	1.5	0.1	2.7	1.6
Other Assets	0	0	0	0	0	0	0	0
Total Assets	531.2	453.3	447.3	462.6	439.3	119.7	22.4	9.8
LIABILITIES
Accounts Payable	6.9	10.3	4.7	2.5	2.1	1.9	1.5	1.1
Short Term Debt	0.3	1.1	3.6	2.4	0	5.8	0	1.0
Other Current Liabilities	41.1	36.3	27.8	19.3	12.1	7.5	5.3	3.1
Total Current Liabilities	49.4	47.7	36.1	24.9	20.9	15.3	6.7	5.2
Long Term Debt	9.7	14.2	11.5	6.9	0	19.3	24.5	17.6
Deferred Tax Income	1.6	0.2	0.4	0.6	0	0	0	0
Other Liabilities	14.7	0	90 K	18.4	1.0	55 K	1.2	1.3
Total Liabilities	75.4	62.1	48.2	50.8	23.6	34.6	32.5	24.1
EQUITY
Common Stock	28 K	27 K	27 K	25 K	25 K	17 K	1.92 K	1.9 K
Retained Earnings	(200.1)	(218.4)	(160.9)	(93.8)	(62.5)	(52.2)	(57.5)	(51.1)
Other Accumulative Comprehensive Income/Loss	0.2	0.1	(0.4)	0	0	(119.7)	(0.9)	(0.6)
Total Equity	455.8	391.3	399.1	411.7	415.7	85.1	(10.1)	(14.3)
Total Liabilities and Equity	531.2	453.3	447.3	462.6	439.3	119.7	22.4	9.8
SHARES OUTSTANDING
Common Shares Outstanding	27.8	26.8	26.1	25.1	18.9	8.6	10.7	9.8

Free